89bio Company

89Bio is a biopharmaceutical company building a pipeline of biologic and small molecule treatments for liver and metabolic disorders.
Technology: Data-driven Technologies
Industry: PharmTech
Headquarters: San Francisco, California, United States
Founded Date: 2018
Employees Number: 11-50
Funding Status: IPO
Investors Number: 4
Total Funding: £27M
Estimated Revenue: $1M to $10M
Last Funding Type: Series A

Visit Website
Register and Claim Ownership